Key points are not available for this paper at this time.
There is still high morbidity and mortality from malaria in Sub-Saharan Africa and Nigeria. Reports of the emergence of resistance to artemisinin combination therapy, will aggravate the situation. This study evaluated the in vivo antiplasmodial activities of aqueous and n- hexane fractions of Citrullus lanatus leaf extracts in mice infected with Plasmodium berghei berghei. Median lethal-dose (LD50) of the extracts were determined using Lorke’s method. The antiplasmodial activity was investigated using three standard methods: a 4-day suppressive, curative and prophylactic tests. Tests groups were administered three graded doses (50, 100 and 200 mg/kg) of the extracts. Chloroquine (5 mg/kg) and pyrimethamine (1.2 mg/kg) were used as positive controls while normal saline (10 mL/kg) was the negative control. Preliminary phytochemical screening revealed the presence of alkaloids, saponins, flavonoids, tannins, phytosterols, reducing sugars and phenolic compounds. The antimalarial activity of both fractions showed significant (p < 0.05) dose-dependent reductions in parasitaemia compared to the negative control. For suppressive test, the aqueous and nhexane fractions of Citrullus lanatus at their highest doses (200 mg/kg), gave maximum of 90.95% & 74.07% chemo-suppression respectively comparable to 94.65% for chloroquine. For curative test, the aqueous fractions showed significant (p < 0.002) schizonticidal activity at all doses. The prophylactic effect of the n- hexane fraction showed significant reductions in parasitaemia (p < 0.05) at all doses. This result demonstrates that the leaf of Citrullus lanatus possesses significant antiplasmodial activity and is safe for the ethnomedicinal management of malaria.
Umaru et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: